Holen Sie sich die Stockscreener-App
1.35
0.75%
0.01
Vorhandelsmarkt:
1.38
0.03
+2.22%
Schlusskurs vom Vortag:
$1.34
Offen:
$1.33
24-Stunden-Volumen:
1.23M
Relative Volume:
0.12
Marktkapitalisierung:
$99.26M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-22.83M
KGV:
-1.7089
EPS:
-0.79
Netto-Cashflow:
$-20.87M
1W Leistung:
-8.16%
1M Leistung:
-51.96%
6M Leistung:
+175.62%
1J Leistung:
+176.53%
1-Tages-Spanne:
$1.33
$1.42
1-Wochen-Bereich:
$1.32
$1.54
52-Wochen-Spanne:
$0.2223
$3.83
Cognition Therapeutics Inc Stock (CGTX) Company Profile
Firmenname
Cognition Therapeutics Inc
Sektor
Branche
Telefon
412-481-2210
Adresse
2403 SIDNEY STREET, PITTSBURGH
Vergleichen Sie CGTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CGTX
Cognition Therapeutics Inc
|
1.35 | 118.22M | 0 | -22.83M | -20.87M | -0.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
376.62 | 97.36B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
576.98 | 60.19B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.37 | 59.56B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
729.76 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
329.84 | 36.14B | 3.81B | -644.79M | -669.77M | -6.24 |
Cognition Therapeutics Inc Stock (CGTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-19 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2024-07-30 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2021-11-03 | Eingeleitet | B. Riley Securities | Buy |
| 2021-11-03 | Eingeleitet | Oppenheimer | Outperform |
Cognition Therapeutics Inc Aktie (CGTX) Neueste Nachrichten
Cognition Therapeutics Announces $30.1M Direct Offering - MSN
Cognition Therapeutics, Inc. (NASDAQ:CGTX) Short Interest Up 47.8% in August - MarketBeat
Analyst Upgrade: Will Cognition Therapeutics Inc outperform tech stocksMarket Activity Summary & Free Long-Term Investment Growth Plans - khodrobank.com
FOMO Trade: Is Cognition Therapeutics Inc a good stock for dollar cost averagingPortfolio Gains Report & Technical Pattern Recognition Alerts - خودرو بانک
Earnings Miss: Is Cognition Therapeutics Inc stock a top performer YTDWeekly Stock Report & Real-Time Stock Entry Alerts - خودرو بانک
Published on: 2025-09-19 07:05:54 - خودرو بانک
Loss Report: Is Cognition Therapeutics Inc stock a top performer YTDEarnings Beat & Capital Protection Trading Alerts - khodrobank.com
Technical Analysis: Is Axsome Therapeutics Inc gaining market share2025 Support & Resistance & Consistent Profit Trading Strategies - khodrobank.com
Earnings Risk: Whats the fair value of Cognition Therapeutics Inc stock2025 Analyst Calls & High Accuracy Investment Signals - khodrobank.com
Is Cognition Therapeutics Inc stock heavily shortedPortfolio Update Report & Community Driven Trade Alerts - خودرو بانک
Geopolitics Watch: Can EWCZ outperform in the next rallyRisk Management & AI Powered Market Entry Ideas - khodrobank.com
Smart Money: Is Cognition Therapeutics Inc. a good stock for dollar cost averagingPortfolio Update Summary & AI Based Trade Execution Alerts - خودرو بانک
Earnings Recap: Can Cognition Therapeutics Inc reach resistance levels soonJuly 2025 Levels & Daily Momentum Trading Reports - خودرو بانک
IPO Launch: Can Cognition Therapeutics Inc disrupt its industryWeekly Gains Summary & Real-Time Volume Surge Alerts - خودرو بانک
Update Recap: Is BARK stock a falling knife or bargain buy2025 Volume Leaders & Safe Capital Investment Plans - khodrobank.com
Update Recap: Is Cognition Therapeutics Inc in a long term uptrendOptions Play & Community Verified Trade Signals - خودرو بانک
FOMO Trade: Will Cognition Therapeutics Inc outperform tech stocksJuly 2025 Catalysts & Long-Term Growth Plans - خودرو بانک
Risk Check: Does Cognition Therapeutics Inc. have pricing power2025 Sector Review & Daily Stock Trend Watchlist - khodrobank.com
Cognition Therapeutics Advances Zervimesine to Phase 3 Trials - TipRanks
Weekly Recap: Whats next for Cognition Therapeutics Inc stockGlobal Markets & AI Based Buy/Sell Signal Reports - خودرو بانک
Aug Mood: Is Cognition Therapeutics Inc. trading at a discountPortfolio Update Summary & Daily Risk Controlled Trade Plans - خودرو بانک
Cognition Therapeutics (NASDAQ:CGTX) Stock Rating Upgraded by Wall Street Zen - MarketBeat
CGTX Q3 EPS Estimate Raised by Brookline Capital Management - MarketBeat
Is Cognition Therapeutics Inc. a good stock for dollar cost averagingPortfolio Value Summary & Weekly Top Performers Watchlists - Lancaster City Council
Cognition Therapeutics Regains Compliance With Nasdaq Minimum Bid Price Requirement - 富途牛牛
Visualizing Cognition Therapeutics Inc. stock with heatmapsPortfolio Growth Summary & Community Supported Trade Ideas - Newser
Cognition Therapeutics Regains Nasdaq Compliance - MSN
Cognition Therapeutics Inc. stock retracement – recovery analysisInsider Buying & Daily Stock Trend Watchlist - Newser
Is Cognition Therapeutics Inc. Forming a Bottom PatternMarket Sentiment Review & Weekly Momentum Stock Picks - beatles.ru
Chart overlay techniques for tracking Cognition Therapeutics Inc.2025 Stock Rankings & Scalable Portfolio Growth Ideas - Newser
Cognition Therapeutics Inc. stock prediction for this weekTreasury Yields & Daily Chart Pattern Signal Reports - Newser
Tick level data insight on Cognition Therapeutics Inc. volatilityMarket Trend Report & Fast Moving Stock Trade Plans - Newser
Can Cognition Therapeutics Inc. keep up with sector leaders2025 Bull vs Bear & Free Community Consensus Stock Picks - خودرو بانک
Neurology biopharmas rebound on trial catalysts and Q2 gains - BioWorld MedTech
What moving averages say about Cognition Therapeutics Inc.2025 Retail Activity & High Yield Stock Recommendations - Newser
Exit Recap: Is Cognition Therapeutics Inc. a stock for growth or value investorsWeekly Market Report & Growth Focused Investment Plans - خودرو بانک
Backtesting results for Cognition Therapeutics Inc. trading strategiesMarket Risk Report & Reliable Entry Point Trade Alerts - Newser
Published on: 2025-09-05 00:35:53 - Newser
Published on: 2025-09-05 00:14:17 - Newser
Real time pattern detection on Cognition Therapeutics Inc. stockRisk Management & Advanced Technical Signal Analysis - Newser
Cognition Therapeutics Announces $30 Million Registered Direct Offering of Common Stock - 富途牛牛
Support Zone Holds Steady for Cognition Therapeutics Inc. After DipMarket Weekly Review & Weekly High Conviction Ideas - Newser
Multi asset correlation models including Cognition Therapeutics Inc.Market Activity Report & Daily Profit Maximizing Trade Tips - Newser
Cognition Therapeutics Inc. stock trend forecastTrade Entry Summary & Breakout Confirmation Trade Signals - Newser
Cognition’s Alzheimer’s drug trial reaches 75% enrollment milestone By Investing.com - Investing.com Canada
Top chart patterns to watch in Cognition Therapeutics Inc.Weekly Trend Report & Safe Capital Growth Plans - Newser
How to manage a losing position in Cognition Therapeutics Inc.Earnings Overview Report & Low Risk High Win Rate Picks - Newser
Can Cognition Therapeutics Inc. recover in the next quarter2025 Retail Activity & Daily Profit Focused Stock Screening - Newser
How sentiment analysis helps forecast Cognition Therapeutics Inc.Quarterly Growth Report & Daily Entry Point Alerts - Newser
Real time scanner hits for Cognition Therapeutics Inc. explainedTreasury Yields & Community Verified Swing Trade Signals - Newser
Cognition Therapeutics closes $30 million registered direct offering By Investing.com - Investing.com Australia
Finanzdaten der Cognition Therapeutics Inc-Aktie (CGTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.30%
2.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):